A public debate is quickly escalating over a new policy from Belize’s Ministry of Health and Wellness that imposes mandatory prescription requirements for all forms of hormonal contraception, including birth control pills, patches and injections. The rule has already divided public health stakeholders, with the ministry defending the change as a critical patient safety measure while women’s reproductive health advocates warn it will cut off access for vulnerable groups across the country.
Shortly after posting a brief announcement about the policy on its official Facebook page, the ministry declined to answer further questions from media, confirming only that Director of Health Services will deliver a full public briefing on the measure next Monday. In its initial public statement, the ministry explained that the new requirement is designed to guarantee that hormonal contraceptives are only used after a full review of a patient’s unique health profile. These medications carry known health risks that can vary widely from person to person, the argument goes, so individualized medical assessment is necessary to prevent adverse outcomes.
Specifically, ministry officials note that clinicians will screen for key risk factors including a history of blood clots or stroke, chronic high blood pressure, regular tobacco use, chronic migraines, and other pre-existing underlying health conditions before writing a prescription. To push back against early criticism that the rule will restrict access, the ministry also emphasized that valid prescriptions can be issued for up to 12 months, and routine contraceptive consultations also provide opportunities for patients to access a wider range of complementary reproductive health services.
But the policy has already drawn fierce pushback from leading women’s health advocates, who argue the unanticipated change will undo decades of incremental progress expanding reproductive autonomy in Belize. Joan Burke, executive director of the Belize Family and Life Association (BFLA) — an organization founded in 1985 to address soaring adolescent pregnancy rates — told reporters the new mandate puts low-income, rural and marginalized women and girls in particularly dangerous positions.
Burke’s core criticism centers on the dramatic cost increase the requirement will impose on contraceptive users. Previously, over-the-counter hormonal contraceptives cost roughly $10 on average; once mandatory doctor consultation fees are added, that total jumps to $85 or more per cycle. For women living in rural areas with limited access to affordable healthcare, or for women in abusive or controlling relationships where they do not have independent access to household funds, that cost increase acts as an insurmountable barrier to access, she explained.
“Just imagine having to find $85 for a month, getting that $85 from the person who basically controls you every day,” Burke said. She warned that cutting off access to reliable contraception will lead to a wave of negative public health outcomes, including increased rates of unintended teen pregnancy, higher rates of preventable maternal health complications, and a rise in the number of people seeking unsafe, unregulated abortions.
Notably, Burke clarified that BFLA does not oppose voluntary medical consultations for contraceptive users — the organization only objects to making prescriptions a legal mandate. “We are not opposed to consultation. But to have it that a prescription is required, I am not in favour of that,” she said. “We are putting so many women and girls at risk by that decision.” Burke also questioned whether the ministry conducted sufficient stakeholder consultation before rolling out the new rule, and called on policymakers to reverse course and re-evaluate the policy.
As the debate continues to grow, the public will have to wait until Monday for further official details from the Ministry of Health and Wellness on the implementation and timeline of the new prescription requirement.